Proxy Votes Now

Home › Funds › JANUS INVESTMENT FUND › Janus Henderson Venture Fund

Janus Henderson Venture Fund (JANVX) proxy voting record 2025-2026

Fund family: JANUS INVESTMENT FUND · Filed by JANUS INVESTMENT FUND (CIK 277751) · SEC series S000010488

Share classes and tickers: JANVX (C000083533), JAVTX (C000028950), JVTAX (C000100475), JVTCX (C000100476), JVTIX (C000100477), JVTNX (C000114881), JVTSX (C000100478)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 941 with, 3 against, 0 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 1 FOR, 3 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with JANUS INVESTMENT FUND as a whole

The same two figures as JANUS INVESTMENT FUND’s manager page (17,858 ballot items across 30 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsJANUS INVESTMENT FUNDItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)95.2%91697.2%15,061
Backed environmental and social shareholder proposals at US companiesn/a23.6%392

Where this fund voted differently from most JANUS INVESTMENT FUND funds

Each ballot item this fund voted is set against the votes of the other JANUS INVESTMENT FUND funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most JANUS INVESTMENT FUND funds on 3 items (1.9% of the 161 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost JANUS INVESTMENT FUND fundsMgmtResult
Revolution Medicines, Inc.2026-06-18To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis BorisyWithholdFOR — 7 of 9 JANUS INVESTMENT FUND fundsAgainstPassed (calculated), 79.1% support
BridgeBio Pharma, Inc.2026-06-22To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares.AgainstFOR — 4 of 5 JANUS INVESTMENT FUND fundsAgainstApproved, 82.9% support
BridgeBio Pharma, Inc.2026-06-22To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly eleWithholdFOR — 4 of 5 JANUS INVESTMENT FUND fundsAgainstPassed (calculated), 80.1% support

Download all 3 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 84.9% of this fund’s 944 such votes could be given a sector; the other 143 (15.1%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care23210.4%
Industrials15200.0%
Consumer Discretionary13710.7%
Technology12410.8%
Finance7900.0%
Energy2100.0%
Miscellaneous1600.0%
Consumer Staples1400.0%
Telecommunications1400.0%
Real Estate1200.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections6290
Audit-related1220
Say-on-Pay1070
Compensation420
Corporate Governance231
Capital Structure150
Extraordinary Transactions110
Shareholder Rights and Defenses30
Other20
Other Social Issues21

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Glaukos CorporationMay 28, 2026$159M40
Ligand Pharmaceuticals IncorporatedJune 5, 2026$80M110
Casey's General Stores, Inc.September 3, 2025$70M151
Perimeter Solutions, Inc.May 28, 2026$63M100
SS&C Technologies Holdings, Inc.May 20, 2026$62M60
Revolution Medicines, Inc.June 18, 2026$61M40
Sensient Technologies CorporationApril 23, 2026$56M110
OSI Systems, Inc.December 11, 2025$51M80

Notable votes against management

MeetingCompanyProposalFundMgmt
September 3, 2025Casey's General Stores, Inc.Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposalAgainstFor
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalAgainstFor
May 5, 2026Tyler Technologies, Inc.Shareholder Proposal Regarding Political Spending. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

957 ballot items at 123 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Janus Henderson Venture Fund (JANVX) voted at 123 shareholder meetings of 120 companies, on 957 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 3 times. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 4 shareholder proposals. It voted FOR the board's own proposals less often than JANUS INVESTMENT FUND's funds as a whole (95.2% against 97.2%). It voted differently from most JANUS INVESTMENT FUND funds on 3 items. 2 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of JANUS INVESTMENT FUND’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.